Richmond Biosciences Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
- Paid Up Capital ₹ 3.98 M
- Company Age 35 Year, 11 Months
- Last Filing with ROC 31 Mar 2022
- Open Charges ₹ 1.89 Cr
- Satisfied Charges ₹ 0.45 M
- Revenue Growth %
- Profit Growth 0.41%
- Ebitda 0.41%
- Net Worth -3.28%
- Total Assets -1.89%
About Richmond Biosciences
Richmond Biosciences Private Limited (RBPL) is a Private Limited Indian Non-Government Company incorporated in India on 16 February 1989 and has a history of 35 years and 11 months. Its registered office is in Hyderabad, Telangana, India.
The Corporate was formerly known as Vadlamani Intermediates And Chemicals Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2022. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 3.98 M.
The company currently has active open charges totaling ₹1.89 Cr. The company has closed loans amounting to ₹0.45 M, as per Ministry of Corporate Affairs (MCA) records.
Sudhir Srivastava and Tripti Srivastava serve as directors at the Company.
Company Details
-
Location
Hyderabad, Telangana, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24110TG1989PTC009623
-
Company No.
009623
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
16 Feb 1989
-
Date of AGM
29 Sep 2022
-
Date of Balance Sheet
31 Mar 2022
-
Listing Status
Unlisted
-
ROC Code
Roc Hyderabad
Industry
Who are the key members and board of directors at Richmond Biosciences?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sudhir Srivastava
|
Director | 26-Jun-2015 | Current |
|
Tripti Srivastava
|
Director | 02-Mar-2007 | Current |
Financial Performance of Richmond Biosciences.
Richmond Biosciences Private Limited, for the financial year ended 2018, experienced no change in revenue, with a 0% increase. The company also saw a slight improvement in profitability, with a 0.41% increase in profit. The company's net worth dipped by a decrease of 3.28%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Richmond Biosciences?
In 2018, Richmond Biosciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Richmond Vivek Laboratories Private LimitedSudhir Srivastava and Tripti Srivastava are mutual person
Charges (Loans)
₹18.87 M
₹0.45 M
Charges Breakdown by Lending Institutions
- State Bank Of India : 1.65 Cr
- A.P.S.F.C. : 0.21 Cr
- A.P.S.F.C : 0.03 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 26 Jul 2007 | State Bank Of India | ₹1.50 Cr | Open |
| 06 May 1998 | State Bank Of India | ₹1.03 M | Open |
| 30 Apr 1991 | A.P.S.F.C | ₹0.32 M | Open |
| 15 Apr 1991 | State Bank Of India | ₹0.45 M | Open |
| 23 Jul 1990 | A.P.S.F.C. | ₹2.07 M | Open |
How Many Employees Work at Richmond Biosciences?
Unlock and access historical data on people associated with Richmond Biosciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Richmond Biosciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Richmond Biosciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
